ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,407Medicare Part D Prescriptions Filled, Including Refills

Rank: 393 out of 3734

$908K Total Retail Price of All Prescriptions

Rank: 146 out of 3734

331 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 398 383 1 4
FUROSEMIDE 395 380 2 7
LEVOTHYROXINE SODIUM 360 354 3 2
PRAVASTATIN SODIUM 338 305 4 15
ALLOPURINOL 295 269 5 33
METOPROLOL SUCCINATE 265 246 6 14
AMLODIPINE BESYLATE 202 195 7 5
NAMENDA 200 200 8 44
SIMVASTATIN 198 189 9 1
WARFARIN SODIUM 178 163 10 10
CRESTOR 170 166 11 28
HYDROCODONE-ACETAMINOPHEN 168 150 S3 12 12
RAMIPRIL 156 135 13 91
DIOVAN 151 123 14 31
ISOSORBIDE MONONITRATE ER 147 142 15 34
EXELON 146 146 16 150
SPIRONOLACTONE 139 131 17 80
METOPROLOL TARTRATE 134 131 18 6
DONEPEZIL HCL 133 133 19 25
ATORVASTATIN CALCIUM 132 122 20 11
TRAMADOL HCL 125 124 21 20
NIASPAN 111 99 22 125
CARVEDILOL 108 81 23 30
HYDROCHLOROTHIAZIDE 108 108 23 9
DIOVAN HCT 107 95 25 72
POTASSIUM CHLORIDE 102 95 26 19
METFORMIN HCL 100 96 27 8
GABAPENTIN 98 94 28 17
SERTRALINE HCL 95 82 29 18
LISINOPRIL 95 95 29 3
CYMBALTA 94 84 31 67
FAMOTIDINE 91 90 32 60
MIRTAZAPINE 87 87 33 45
VENLAFAXINE HCL ER 87 84 33 84
ALENDRONATE SODIUM 86 86 35 26
RISPERIDONE 84 82 36 62
TAMSULOSIN HCL 83 59 37 29
BYSTOLIC 76 76 38 148
VYTORIN 71 71 39 163
ROPINIROLE HCL 69 69 40 118
LIPITOR 68 61 41 90
POLYETHYLENE GLYCOL 3350 68 68 41 53
ESCITALOPRAM OXALATE 66 66 43 68
CLOPIDOGREL 65 55 44 23
JANUVIA 64 64 45 50
MELOXICAM 61 52 46 52
CELEBREX 60 60 47 69
NEXIUM 59 47 48 36
CITALOPRAM HBR 57 46 49 16
DILTIAZEM 24HR CD 57 57 49 97
RESTASIS 57 57 49 325
GLIMEPIRIDE 57 48 49 37
RANITIDINE HCL 56 53 53 32
ADVAIR DISKUS 56 52 53 35
PLAVIX 55 45 55 39
LOVAZA 55 52 55 143
BENICAR 52 52 57 107
OXYCODONE-ACETAMINOPHEN 52 27 S2 57 51
FLUOXETINE HCL 51 32 59 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.